# Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

> **NCT00880191** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 430 (actual)

## Conditions studied

- Nausea and Vomiting
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** gabapentin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00880191
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-03
- **Final completion:** 2015-05
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880191, "Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00880191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*